PubRank
Search
About
Stéphanie Graff-Dubois
Author PubWeight™ 18.73
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Macrophage plasticity in experimental atherosclerosis.
PLoS One
2010
2.75
2
Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.
J Clin Immunol
2007
1.57
3
Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection.
J Immunol
2010
1.28
4
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.
J Clin Invest
2004
1.26
5
Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases.
J Immunol
2008
1.15
6
TCR stimulation drives cleavage and shedding of the ITIM receptor CD31.
J Immunol
2010
1.15
7
HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy.
J Immunol
2002
1.06
8
EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes.
Cancer Res
2003
1.06
9
Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis.
J Immunol
2010
1.05
10
STEAP, a prostate tumor antigen, is a target of human CD8+ T cells.
Cancer Immunol Immunother
2006
0.93
11
CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
PLoS Pathog
2011
0.87
12
Immune responses elicited in tertiary lymphoid tissues display distinctive features.
PLoS One
2010
0.86
13
Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes.
Int J Cancer
2004
0.82
14
Antiangiogenic treatment prevents adventitial constrictive remodeling in graft arteriosclerosis.
Transplantation
2008
0.81
15
Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
Ann N Y Acad Sci
2007
0.79
16
The HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection.
Retrovirology
2015
0.79
17
Induction of multiple CD8+ T cell responses against the inducible Hsp70 employing an Hsp70 oligoepitope peptide.
Oncol Rep
2007
0.76